Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study.
Saved in:
| Title: | Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study. |
|---|---|
| Authors: | Nikkilä A; Tampere Center for Child Health Research, Tampere University, Tampere, Finland. atte.nikkila@tuni.fi.; Tays Cancer Center, Tampere University Hospital, Tampere, Finland. atte.nikkila@tuni.fi., Lohi O; Tampere Center for Child Health Research, Tampere University, Tampere, Finland.; Tays Cancer Center, Tampere University Hospital, Tampere, Finland., Abrahamsson J; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Griskevicius L; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius, Lithuania., Hallböök H; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Jónsson ÓG; Department of Pediatrics, Landspitali University Hospital, Reykjavík, Iceland., Lund B; Department of Pediatrics, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Marquart HV; Department of Clinical Immunology, Copenhagen University Hospital (rigshospitalet), Copenhagen, Denmark.; Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark., Overgaard U; Department of Hematology. National Hospital, Copenhagen, Denmark., Palk K; Department of Hematology, North Estonia Medical Centre, Tallinn, Estonia., Pruunsild K; Department of Onco-haematology, Talinn Children's Hospital, Talinn, Estonia., Quist-Paulsen P; Department of Hematology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Toft N; Department of Hematology, Rigshospitalet University Hospital, Copenhagen, Denmark., Vaitkeviciene GE; Center for Pediatric Oncology and Hematology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Wartiovaara-Kautto U; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Heyman M; Childhood Cancer Research Unit, Karolinska Institute, Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Vettenranta K; University of Helsinki and Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland., Schmiegelow K; Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Pediatrics and Adolescent Medicine, Rigshospitalet University Hospital, Copenhagen, Denmark. |
| Source: | Leukemia [Leukemia] 2026 Jan; Vol. 40 (1), pp. 215-218. Date of Electronic Publication: 2025 Oct 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
